What's missing from the approval of the booster dose of the COVID-19 vaccine?
2021-09-16T13:12:16.813Z
Pfizer insists that the effectiveness of its vaccine diminishes after six to eight months, so the FDA is analyzing the data. In two days the agency will meet in a committee to decide if the additional dose is recommended.